Method for treating or preventing inflammatory diseases
CA 2465894 A1 · Owner: Yerxa, Benjamin R. · Inventors: Yerxa, Benjamin R.; Peterson, Ward M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of preventing or treating aninflammatory disease, including but not limited to sinusitis, rhinitis, conjunctivitis,asthma dermatitis, inflammatory bowel disease inflammatory , collagen vasculardiseases glomerulonephritis, inflammatory skin diseases and , sarcoidosis. The method comprises administrating to a subject a pharmaceutical formulation comprising a nucleotide receptor agonist such as nucleoside , diphosphate, nucleoside triphosphate or dinucleoside polyphosphate, according to general formula Ia, IBC, IIa, Ii, or III. Preferred in dications of the present invention are perennial allergic rhinitis seasonal allergic rhinitis, infectious …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 6, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 6, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 6, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.